Press Releases

Welcome to the Investing News Network's press release section, where you can stay informed with past and present announcements from our clients. Explore the latest stock news from mining, technology and life science companies and gain an investing edge by staying up to date with today's press releases.
Filters
Clear All Filters
Filter ✕

Date Range

Sector

Seegnal (SEGN:CA)

Seegnal Presents Real-World Evidence on Reducing Fall Risk in Geriatric Patients at Caltcm Summit

medical-device-investing
Solvonis Therapeutics (None)

Expansion of SVN-015 into Depression Following Positive Preclinical Data

pharmaceutical-investing
Cardiol Therapeutics (CRDL:CC)

Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million

biotech-investing
Cardiol Therapeutics (CRDL:CC)

Cardiol Therapeutics Announces Bought Deal Financing for Gross Proceeds of $13.5 Million

biotech-investing
Cardiol Therapeutics (CRDL:CC)

Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million

biotech-investing
Seegnal (None)

Seegnal's Investor Meet & Greet with Corporate CEO, Mr. Elad Bibi-Aviv

artificial-intelligence-investin
Cardiol Therapeutics (CRDL:CC)

Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

biotech-investing
Lobe Sciences (LOBE:CC)

Lobe Sciences Advances Governance and Capital Markets Expertise with Appointment of Mr. Nick Karakochuk to the Board of Directors

psychedelics-investing
Lobe Sciences (LOBE:CC)

Lobe Sciences Reports FY2025 with a Stronger Balance Sheet and Sharpened Strategy

psychedelics-investing
Solvonis Therapeutics (None)

U.S. Patent allowance received for PTSD discovery programme

psychedelics-investing
Seegnal (TSXV:SEGN)

Seegnal's operating subsidiary Seegnal E-Health Ltd. hires AI VP to Strengthen AI Capabilities and Accelerates Development of Seegnal Guard

artificial-intelligence-investin
Lobe Sciences (LOBE:CC)

Lobe Sciences Reports Fiscal 2025 Results and Highlights Strategic Transformation Following Leadership Transition

psychedelics-investing
InMed Pharmaceuticals (INM)

InMed Announces Results of 2025 Annual General and Special Meeting

pharmaceutical-investing
InMed Pharmaceuticals (INM)

InMed Provides Update on BayMedica Commercial Business

pharmaceutical-investing
Nextech3D.ai (NTAR:CC)

Nextech3D.ai Announces Definitive Agreement to Acquire 100% of ARway, Streamlining Operations

artificial-intelligence-investin
Cardiol Therapeutics (CRDL:CA)

New Data from the Phase II ARCHER Trial Demonstrate CardiolRx Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions

biotech-investing
Nextech3D.ai (NTAR:CC)

Nextech3D.ai Accelerates Eventdex Integration; Expands AI Matchmaking and Achieves Milestone Production of 800 Interactive Floor Plans in 2025

artificial-intelligence-investin

InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901

pharmaceutical-investing
Nextech3D.ai (NTAR:CC)

Nextech3D.ai Poised for Growth as Event-Tech and 3D/AR Revenue Accelerates

artificial-intelligence-investin
Cardiol Therapeutics (CRDL:CA)

Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040

biotech-investing

Latest News

More News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES